Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PETMED EXPRESS INCPETS · Entity 7326 | Director · CEO and President | September 28, 2026 | September 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PETMED EXPRESS INC
Report date September 28, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 250,000 |
Reported balance
After 2026-09-28 transaction · row 1
1 source rowRow 1 · 2026-09-28 · Grant · Acquired 250,000 · Balance 250,000 F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Inducement Incentive Plan that will vest as to one-third of the granted shares on each of the first three anniversaries of the grant date, subject to continued employment and subject to accelerated vesting upon death, disability, a change of control, or certain terminations of employment. |
| Performance Share UnitsSEC Table II · derivative / convertible security · Expires 2029-09-28 | Direct | 250,000 |
Reported balance
After 2026-09-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-28 · Grant · Acquired 250,000 · Balance 250,000 F2: Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on September 27, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Inducement Incentive Plan that will vest as to one-third of the granted shares on each of the first three anniversaries of the grant date, subject to continued employment and subject to accelerated vesting upon death, disability, a change of control, or certain terminations of employment.
F2: Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on September 27, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 28, 2026 Filed Sep 29, 2026 20:36 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantPerformance Share Units · Derivative | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-26-000064 · wk-form4_1790714172.xml · derivative · entry 2 Willard Jeffrey Allen · CIK 0002155835 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-09-28 F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on September 27, 2029. F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on September 27, 2029. Read SEC document |
| September 28, 2026 Filed Sep 29, 2026 20:36 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-26-000064 · wk-form4_1790714172.xml · nonDerivative · entry 1 Willard Jeffrey Allen · CIK 0002155835 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Inducement Incentive Plan that will vest as to one-third of the granted shares on each of the first three anniversaries of the grant date, subject to continued employment and subject to accelerated vesting upon death, disability, a change of control, or certain terminations of employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.